Agwọ ọrịa 'Azitsid', ntuziaka maka ojiji, contraindications

Ọgwụ nje sara mbara-nso ọgwụ "Azitsid" na-ezo aka a ìgwè nke macrolide (azitsidov). Nke a na-eme site a akwa ịta nke nọ n'ọrụ bekee - azithromycin - isi iyi nke ọrịa, bactericidal eke nchebe. E nwere a elu ọgwụ ọrụ megide gram-mma bacteria, na n'aka nke ọzọ, ọ gaghị mmetụta gram-adịghị mma, na-eguzogide ọgwụ dị erythromycin.

"Azithromycin" bụ eguzogide acidic gburugburu, ka absorption nke ọgwụ si eriri afọ tract emee. Drug esịmde kacha ịta n'ime ọbara plasma mgbe 3 awa na ọ nwere a agafeghị oke bioavailability nke 37%. Ọ ga-kwuru a ezi nghọta n'ime urogenital akụkụ na anụ ahụ na akụkụ okuku ume na tract, akpụkpọ adụ anụ ahụ nkwadebe "Azitsid" ntuziaka maka ojiji na-akọwa nke a ala nkịtị na-edozi nke ọbara plasma. "Azithromycin" na-anapụta ndị akwa ịta nke phagocytes ọrịa saịtị, na a tọhapụrụ na usoro nke phagocytosis, enweghị na-eme ihe ọ bụla na-ezighị ezi mmetụta na ha.

N'ime otu izu, ọgwụ nwere ike nọgidere na-enwe na akwa ịta na foci nke ọrịa, egosipụta n'ọrụ mgwa ogbo 2, a na-enye ohere na-ọgwụ otu ugboro n'ụbọchị.

Mgbu na-efe efe nke dị iche iche agwa bụ na-egosi maka ọgwụgwọ na "Azitsid" ntuziaka maka ojiji na-emeso ha otú ahụ ọrịa, nke na-kpatara microorganisms chebaara ọgwụ. Nke a na-agụnye ndị na-esonụ na-efe efe:

- urogenital;

- elu akụkụ okuku ume na tract, e.g., tonsillitis, tonsillitis, otitis media , wdg na otolaryngology ;.

- ala akụkụ okuku ume na tract, dị ka SARS;

- akpụkpọ adụ anụ ahụ (impetigo, sekọndrị dermatoses);

- mbụ ogbo nke ọrịa Lyme;

- duodenal ọnyá afọ ọrịa, gastric daa ọrịa.

Ná nhọpụta nke ọgwụgwọ dị mkpa iji soro dosing Usoro "Azitsid" ọgwụ ọjọọ, ntụziaka ntuziaka tụrụ aro na-ewere ọgwụ mgbe a nri otu ugboro n'ụbọchị na doses kenyere na n'otu n'otu.

Site ụfọdụ usoro nke ahụ mmetụta nwere ike ime ka a N'ihi nke inweta "Azitsid" nkwadebe ndu na-akọwa-ekwe omume nke na-adịghị mma ngosipụta nke omumu na urinary usoro, n'ụdị nke anabata ma ọ bụ dermatological Jeremaya mere. Na ụmụaka, ọgwụgwọ nwere ike ime ka itching, conjunctivitis na urticaria.

Siri ike gbasara akụrụ na hepatic odida na-atụle ga-eme ka discontinuation ọgwụgwọ ọgwụ ọjọọ, "Azitsid" ntụziaka ntuziaka na-ezo aka ọtụtụ contraindications na-akwanyere ndị na ngwá ọrụ:

- ụmụ noo n'okpuru 3 hlet ma ọ bụ erikpu erughị 25 n'arọ:

- Akwa uche ọgwụ:

- Akwa uche na macrolide ọgwụ nje.

Ọgwụgwọ pụtara "Azitsid" n'oge ime bụ omume, ma naanị na ikpe nke kara erite uru site na-ewere a ọgwụ n'ihi na ndị inyom na ndị nwere ihe ize ndụ maka nwa ọhụrụ.

Na ihe ovadozu nke na nkà mmụta ọgwụ "Azitsid" ka otu mgbaàmà dị ka na nke mmetụta, ma na ha apụta adịkwu ụdị. Nke a nwere ike vomiting, oké ọgbụgbọ na afọ ọsịsa, na o kwere omume nwa oge ntị ọnwụ. Dị ka ọgwụgwọ iri ọrụ unyi, gastric lavage na ndị ọzọ na symptomatic ọgwụ.

Tupu oru nke ọgwụ "Azitsid" dị ka a usọbọ kwesịrị-ege ntị na ya na mmekọrịta ya na ndị ọzọ ọgwụ. Mbụ niile, ọ ga-echebe megide a kwere omume ovadozu, na-eme n'ihi na nke ibe mkwado ụfọdụ ego. Ka ihe atụ, na itinye "Azitsid" ọnụ na digoxin hụrụ na ụba ịta nke ikpeazụ na ahu na chloramphenicol na tetracycline welie edinam nke azithromycin. Yiri ọnọdụ ọgwụ interactions na-kọwara n'ụzọ zuru ezu na ntuziaka ka ọgwụ.

The kacha adị ndụ nke ọgwụ bụ 2 afọ, ọ na-echekwara nke-apụghị iru nke ụmụaka na a jụụ ebe.